Last updated: April 25, 2026
Which suppliers actually produce and supply TWIRLA?
TWIRLA is supplied as a transdermal system by Organon LLC in the U.S. (commercial label). The drug is levonorgestrel and ethinyl estradiol, delivered via a transdermal patch (label sections “Description” and “How Supplied”).【1】
The supplier list in public regulatory and label materials is typically constrained to:
1) the market authorization holder / labeler, and
2) the manufacturer(s) and packager(s) named on the FDA label.
For TWIRLA, the determinative publicly indexed entity is Organon LLC as the commercial supplier/labeler in U.S. distribution materials.【1】
Who is the labeler / commercial supplier of record?
Organon LLC
- Named as the supplier/labeler on the U.S. prescribing information for TWIRLA.【1】
Who manufactures or packages the finished dosage form (patch) for distribution?
Publicly indexed label materials identify the finished dosage form as TWIRLA (levonorgestrel and ethinyl estradiol transdermal system) in a patch format, supplied in blister packaging, with specific “How Supplied” presentation details on the U.S. label.【1】
However, the exact site-level manufacturer name(s) and packager name(s) are not explicitly enumerated in the excerpts available from the cited label page. The operative supplier signal that is consistently present in public label metadata is the labeler/supplier: Organon LLC.【1】
What does the supply chain look like at the bill-of-materials level?
A transdermal contraceptive patch has three supply layers:
- API layer: levonorgestrel and ethinyl estradiol (synthetic steroid APIs)
- Device layer: patch components and adhesive laminate system
- Finishing/packaging layer: blister or unit-dose packaging and labeling for distribution
Public label content for TWIRLA confirms the product is a transdermal system delivering levonorgestrel and ethinyl estradiol.【1】 It does not, in the cited label text, disclose the underlying API suppliers or patch component contractors by name.
What is publicly confirmed on the TWIRLA label about supply and presentation?
TWIRLA is supplied as a transdermal system with label-structured presentation and packaging description under “How Supplied.”【1】
Product identity (for supply chain matching):
- Drug: TWIRLA
- Actives: levonorgestrel and ethinyl estradiol
- Dosage form: transdermal system (patch)
- Labeler/supplier: Organon LLC【1】
What suppliers can be cited from public label/regulatory sources?
From the cited public source for TWIRLA U.S. prescribing information, the supplier that can be stated with direct sourcing is:
| Supplier role |
Organization |
What the public record supports |
| Commercial supplier / labeler (U.S.) |
Organon LLC |
Listed on U.S. TWIRLA prescribing information as the supplier/labeler for TWIRLA distribution【1】 |
No other named suppliers (API makers, patch technology OEM, blister packager, or contract manufacturer site) are explicitly extractable from the cited label content provided in the source.
Supplier due diligence checklist for TWIRLA (based on what the label does show)
Given the publicly citable supplier is Organon LLC, business due diligence should map from labeler to supply chain via the typical industry chain of control points that are usually present in full CMC documentation and device master files, but are not listed by name in the cited excerpt:
1) Finished dosage form responsibility (labeler-to-CMO mapping)
- Confirm which entity manufactures and which entity packages (both can differ).
2) API supply (levonorgestrel, ethinyl estradiol)
- Confirm the approved sources listed in CMC documentation tied to the NDA.
3) Transdermal patch system components
- Confirm the adhesive matrix, rate-controlling membrane, and backing film suppliers used for the approved device configuration.
This checklist aligns to the functional supply chain implied by the labeled dosage form: a transdermal delivery system of levonorgestrel and ethinyl estradiol.【1】
What to use this for (commercial and procurement impact)
- For vendor onboarding, the public starting point is Organon LLC as the supplier/labeler of record for U.S. distribution.【1】
- For procurement or partnership targeting, the patch category typically spans specialized device contractors; those names are not disclosed in the cited label content, so contracting strategies should begin with Organon’s CMC/device interface rather than trying to source APIs and device materials directly from publicly listed patch contractors.
Key Takeaways
- Organon LLC is the publicly cited commercial supplier/labeler of record for TWIRLA in the U.S. prescribing information.【1】
- TWIRLA is a levonorgestrel and ethinyl estradiol transdermal patch (transdermal system), confirming the supply chain spans both steroid APIs and a patch device build.【1】
- The cited public label content supports the labeler/supplier identity but does not provide named API suppliers or patch CMOs/packagers beyond the labeler.
FAQs
1) Who is the supplier/labeler of TWIRLA in the U.S.?
Organon LLC is listed as the supplier/labeler on TWIRLA U.S. prescribing information.【1】
2) What active ingredients does TWIRLA require from an API supply standpoint?
TWIRLA contains levonorgestrel and ethinyl estradiol as active ingredients.【1】
3) Is TWIRLA a drug, a device, or both?
TWIRLA is a transdermal system (patch) delivering the drug actives through a patch device configuration as described on the label.【1】
4) Does the public label list API or patch component suppliers by name?
The cited prescribing information source confirms the labeler but does not list named API suppliers or patch component contractors in the provided label text.【1】
5) What is the best publicly anchored supplier contact point for TWIRLA supply?
The publicly anchored point is Organon LLC, as the U.S. labeler/supplier of TWIRLA.【1】
References
[1] U.S. Food and Drug Administration. TWIRLA (levonorgestrel and ethinyl estradiol) prescribing information (label). FDA. (Accessed via FDA label content as cited in this response).
